CVS Health Corporation CVS
At closeNov 6, 2026, 7:44 PM EST
After hours · Nov 6, 7:44 PM ET
- YTD
- +5.66%
- 1 year
- +6.60%
- Market cap
- 107.28B
- Revenue (ttm)
- 418.16B
- Profit margin
- 2.64%
- EPS (ttm)
- 8.61
- Shares out
- 1.28B
- P/E ratio
- 9.74
- Forward P/E
- 9.79
- Dividend
- 2.66 (3.27%)
- Ex-dividend date
- Oct 21, 2026
- YTD return
- +5.66%
- 1-year return
- +6.60%
- Volume
- 16.10M
- Avg volume
- 8.73M
- Open
- 80.70
- Previous close
- 81.33
- Day's range
- 80.69 – 84.37
- 52-week range
- 70.08 – 110.60
- Beta
- 0.58
- Analysts
- Strong Buy
- Price target
- 115.48 (+37.7%)
- Earnings date
- Feb 9, 2027
5D -5.33 (-5.98%)
Key statistics
- Enterprise value
- 164.66B
- PEG ratio
- 0.19
- Price / sales
- 0.26
- Price / book
- 1.33
- Dividend yield
- 3.27%
- Payout ratio
- 30.89%
- Revenue growth
- 5.40%
- Free cash flow
- 11.83B
- Total cash
- 14.89B
- Total debt
- 75.30B
- Return on equity
- 14.36%
- Short % of float
- 1.27%
- 50-day average
- 90.56
- 200-day average
- 88.89
Analyst view
Consensus: strong buy
- Target (low)
- 103.00
- Target (mean)
- 115.48
- Target (high)
- 146.00
- Strong buy7
- Buy18
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate 1.11.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | 1.22 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 1.65 | 2.09 | +0.44 | +26.67% |
| Aug 5, 2026 | Jun 30, 2026 | 1.85 | 2.58 | +0.73 | +39.46% |
| May 6, 2026 | Mar 31, 2026 | 2.18 | 2.57 | +0.39 | +17.89% |
| Feb 10, 2026 | Dec 31, 2025 | 1.00 | 1.09 | +0.09 | +9.00% |
| Oct 29, 2025 | Sep 30, 2025 | 1.37 | 1.60 | +0.23 | +16.79% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2026 | UBS | main | Buy | Buy |
| Nov 5, 2026 | Leerink Partners | main | Outperform | Outperform |
| Nov 5, 2026 | Barclays | main | Overweight | Overweight |
| Oct 12, 2026 | Leerink Partners | main | Outperform | Outperform |
| Sep 3, 2026 | UBS | main | Buy | Buy |
| Aug 19, 2026 | Argus Research | main | Buy | Buy |
About CVS Health Corporation
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- cvshealth.com
News
UBS Maintains Buy on CVS Health, Lowers Price Target to $107 
Leerink Partners Maintains Outperform on CVS Health, Lowers Price Target to $104 
Chipmakers' Growth Beyond Phones, Arm's Server Share Grows - Barclays Maintains Overweight on CVS Health, Lowers Price Target to $107
Huge News for CVS Stock Investors 
What CVS Health (CVS) Said on Its Q3 Earnings Call 
Elizabeth Warren Says CVS Is Still Trying To ‘Rip People Off’ With Planned Breakup as Mark Cuban Says Split ‘Changes Nothing For Patients’ 
48,865 Shares in CVS Health Corporation $CVS Bought by Associated Banc Corp 
Inside CVS Health, a small group of top executives spent months engaged in a strategic review that developed into a secret plan: a decision to split up the $400 billion healthcare giant 
Wednesday's Final Takeaways: CVS Splitting in Two, ORCL Scraps Tencent Deal
Your note
Sign in to keep a note on CVS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN C DAVID II | Director | Stock Award(Grant) | May 13, 2026 | 129,316 |
| CAPOZZI HEIDI B | Officer | Stock Award(Grant) | Mar 30, 2026 | 97,473 |
| COMPTON-PHILLIPS AMY | Officer | Stock Award(Grant) | Mar 30, 2026 | 58,660 |
| COWHEY THOMAS F. | Chief Financial Officer | Stock Award(Grant) | Mar 31, 2025 | 91,297 |
| FARAH ROGER N | Director | Stock Award(Grant) | Nov 28, 2024 | 54,249 |
| JOYNER JOHN DAVID | Chief Executive Officer | Stock Award(Grant) | Mar 30, 2026 | 231,209 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.63% | 123,223,409 | 10.33B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.51% | 83,315,369 | 6.99B | Jun 29, 2026 |
| Capital World Investors | 5.86% | 74,951,955 | 6.28B | Jun 29, 2026 |
| State Street Corporation | 4.71% | 60,283,408 | 5.05B | Jun 29, 2026 |
| Dodge & Cox Inc. | 3.91% | 50,012,765 | 4.19B | Jun 29, 2026 |
| Wellington Management Group, LLP | 2.64% | 33,801,113 | 2.83B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 40,502,867 | 3.40B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.58% | 33,064,695 | 2.77B | Jun 29, 2026 |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 2.48% | 31,708,094 | 2.66B | Jun 29, 2026 |
| WASHINGTON MUTUAL INVESTORS FUND | 2.47% | 31,634,083 | 2.65B | Sep 29, 2026 |
| Income Fund of America | 1.85% | 23,692,996 | 1.99B | Sep 29, 2026 |
| AMERICAN BALANCED FUND | 1.33% | 17,065,948 | 1.43B | Sep 29, 2026 |